STATE STREET CORP - TRANSCODE THERAPEUTICS INC ownership

TRANSCODE THERAPEUTICS INC's ticker is RNAZ and the CUSIP is 89357L105. A total of 14 filers reported holding TRANSCODE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of TRANSCODE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$7,121
-74.8%
21,019
-50.0%
0.00%
Q4 2022$28,292
+23.0%
42,038
+100.0%
0.00%
Q3 2022$23,000
-11.5%
21,0190.0%0.00%
Q2 2022$26,000
-57.4%
21,0190.0%0.00%
Q1 2022$61,000
+17.3%
21,019
+2.0%
0.00%
Q4 2021$52,000
-16.1%
20,6000.0%0.00%
Q3 2021$62,00020,6000.00%
Other shareholders
TRANSCODE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,289,000$1,418,0000.44%
Worth Venture Partners, LLC 324,157$357,0000.22%
Redmond Asset Management, LLC 90,874$100,0000.04%
ACT CAPITAL MANAGEMENT, LLC 6,500$7,0000.01%
K.J. Harrison & Partners Inc 19,987$22,0000.01%
Shay Capital LLC 15,060$17,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 76,549$84,0000.00%
STATE STREET CORP 21,019$23,0000.00%
BlackRock Inc. 15,334$17,0000.00%
View complete list of TRANSCODE THERAPEUTICS INC shareholders